Europe Vitamin K Antagonists (Vka) Industry Market Research Report

SKU ID :Maia-15118931 | Published Date: 23-Jan-2020 | No. of pages: 108
1 Vitamin K Antagonists (Vka) Introduction and Market Overview 1.1 Objectives of the Study 1.2 Definition of Vitamin K Antagonists (Vka) 1.3 Vitamin K Antagonists (Vka) Market Scope and Market Size Estimation 1.3.1 Market Concentration Ratio and Market Maturity Analysis 1.3.2 Europe Vitamin K Antagonists (Vka) Value and Growth Rate from 2014-2024 1.4 Market Segmentation 1.4.1 Types of Vitamin K Antagonists (Vka) 1.4.2 Applications of Vitamin K Antagonists (Vka) 1.4.3 Research Countries 1.5 Market Dynamics 1.5.1 Drivers 1.5.2 Limitations 1.5.3 Opportunities 1.6 Industry News and Policies by Countries 1.6.1 Industry News 1.6.2 Industry Policies 2 Industry Chain Analysis 2.1 Upstream Raw Material Suppliers of Vitamin K Antagonists (Vka) Analysis 2.2 Major Players of Vitamin K Antagonists (Vka) 2.2.1 Major Players Manufacturing Base and Market Share of Vitamin K Antagonists (Vka) in 2018 2.2.2 Major Players Product Types in 2018 2.3 Vitamin K Antagonists (Vka) Manufacturing Cost Structure Analysis 2.3.1 Consumption Process Analysis 2.3.2 Manufacturing Cost Structure of Vitamin K Antagonists (Vka) 2.3.3 Raw Material Cost of Vitamin K Antagonists (Vka) 2.3.4 Labor Cost of Vitamin K Antagonists (Vka) 2.4 Market Channel Analysis of Vitamin K Antagonists (Vka) 2.5 Major Downstream Buyers of Vitamin K Antagonists (Vka) Analysis 3 Europe Vitamin K Antagonists (Vka) Market, by Type 3.1 Europe Vitamin K Antagonists (Vka) Value and Market Share by Type (2014-2019E) 3.2 Europe Vitamin K Antagonists (Vka) Consumption and Market Share by Type (2014-2019E) 3.3 Europe Vitamin K Antagonists (Vka) Value and Growth Rate by Type (2014-2019E) 3.3.1 Europe Vitamin K Antagonists (Vka) Value and Growth Rate of Oral 3.3.2 Europe Vitamin K Antagonists (Vka) Value and Growth Rate of Injection 3.4 Europe Vitamin K Antagonists (Vka) Price Analysis by Type (2014-2019E) 4 Vitamin K Antagonists (Vka) Market, by Application 4.1 Downstream Market Overview 4.2 Europe Vitamin K Antagonists (Vka) Consumption and Market Share by Application (2014-2019E) 4.2.1 Europe Vitamin K Antagonists (Vka) Consumption and Growth Rate of VTE (2014-2019E) 4.2.2 Europe Vitamin K Antagonists (Vka) Consumption and Growth Rate of ACS/MI (2014-2019E) 4.2.3 Europe Vitamin K Antagonists (Vka) Consumption and Growth Rate of AF (2014-2019E) 4.2.4 Europe Vitamin K Antagonists (Vka) Consumption and Growth Rate of Others (2014-2019E) 5 Europe Vitamin K Antagonists (Vka) Consumption, Value ($) by Countries (2014-2019E) 5.1 Europe Vitamin K Antagonists (Vka) Value and Market Share by Countries (2014-2019E) 5.2 Europe Vitamin K Antagonists (Vka) Consumption and Market Share by Countries (2014-2019E) 5.3 Europe Vitamin K Antagonists (Vka) Consumption, Value, Price and Gross Margin (2014-2019E) 5.4 Germany Vitamin K Antagonists (Vka) Consumption, Value, Price and Gross Margin (2014-2019E) 5.5 UK Vitamin K Antagonists (Vka) Consumption, Value, Price and Gross Margin (2014-2019E) 5.6 France Vitamin K Antagonists (Vka) Consumption, Value, Price and Gross Margin (2014-2019E) 5.7 Italy Vitamin K Antagonists (Vka) Consumption, Value, Price and Gross Margin (2014-2019E) 5.8 Spain Vitamin K Antagonists (Vka) Consumption, Value, Price and Gross Margin (2014-2019E) 5.9 Russia Vitamin K Antagonists (Vka) Consumption, Value, Price and Gross Margin (2014-2019E) 6 Competitive Landscape 6.1 Competitive Profile 6.2 Lilly 6.2.1 Company Profiles 6.2.2 Vitamin K Antagonists (Vka) Product Introduction 6.2.3 Lilly Sales, Value, Price, Gross Margin 2014-2019E 6.2.4 Lilly Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 6.3 AstraZeneca 6.3.1 Company Profiles 6.3.2 Vitamin K Antagonists (Vka) Product Introduction 6.3.3 AstraZeneca Sales, Value, Price, Gross Margin 2014-2019E 6.3.4 AstraZeneca Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 6.4 Bristol-Myers Squibb 6.4.1 Company Profiles 6.4.2 Vitamin K Antagonists (Vka) Product Introduction 6.4.3 Bristol-Myers Squibb Sales, Value, Price, Gross Margin 2014-2019E 6.4.4 Bristol-Myers Squibb Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 6.5 The Medicines Company 6.5.1 Company Profiles 6.5.2 Vitamin K Antagonists (Vka) Product Introduction 6.5.3 The Medicines Company Sales, Value, Price, Gross Margin 2014-2019E 6.5.4 The Medicines Company Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 6.6 Genentech (Roche) 6.6.1 Company Profiles 6.6.2 Vitamin K Antagonists (Vka) Product Introduction 6.6.3 Genentech (Roche) Sales, Value, Price, Gross Margin 2014-2019E 6.6.4 Genentech (Roche) Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 6.7 Boehringer Ingelheim 6.7.1 Company Profiles 6.7.2 Vitamin K Antagonists (Vka) Product Introduction 6.7.3 Boehringer Ingelheim Sales, Value, Price, Gross Margin 2014-2019E 6.7.4 Boehringer Ingelheim Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 6.8 Bayer 6.8.1 Company Profiles 6.8.2 Vitamin K Antagonists (Vka) Product Introduction 6.8.3 Bayer Sales, Value, Price, Gross Margin 2014-2019E 6.8.4 Bayer Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 6.9 Aspen 6.9.1 Company Profiles 6.9.2 Vitamin K Antagonists (Vka) Product Introduction 6.9.3 Aspen Sales, Value, Price, Gross Margin 2014-2019E 6.9.4 Aspen Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 6.10 Pfizer 6.10.1 Company Profiles 6.10.2 Vitamin K Antagonists (Vka) Product Introduction 6.10.3 Pfizer Sales, Value, Price, Gross Margin 2014-2019E 6.10.4 Pfizer Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 6.11 Johnson & Johnson 6.11.1 Company Profiles 6.11.2 Vitamin K Antagonists (Vka) Product Introduction 6.11.3 Johnson & Johnson Sales, Value, Price, Gross Margin 2014-2019E 6.11.4 Johnson & Johnson Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 6.12 Daiichi Sankyo 6.12.1 Company Profiles 6.12.2 Vitamin K Antagonists (Vka) Product Introduction 6.12.3 Daiichi Sankyo Sales, Value, Price, Gross Margin 2014-2019E 6.12.4 Daiichi Sankyo Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 6.13 Otsuka 6.13.1 Company Profiles 6.13.2 Vitamin K Antagonists (Vka) Product Introduction 6.13.3 Otsuka Sales, Value, Price, Gross Margin 2014-2019E 6.13.4 Otsuka Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 6.14 Sanofi 6.14.1 Company Profiles 6.14.2 Vitamin K Antagonists (Vka) Product Introduction 6.14.3 Sanofi Sales, Value, Price, Gross Margin 2014-2019E 6.14.4 Sanofi Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 7 Europe Vitamin K Antagonists (Vka) Market Analysis and Forecast by Type and Application 7.1 Europe Vitamin K Antagonists (Vka) Market Value & Volume Forecast, by Type (2019-2024) 7.1.1 Oral Market Value and Volume Forecast (2019-2024) 7.1.2 Injection Market Value and Volume Forecast (2019-2024) 7.2 Europe Vitamin K Antagonists (Vka) Market Value & Volume Forecast, by Application (2019-2024) 7.2.1 VTE Market Value and Volume Forecast (2019-2024) 7.2.2 ACS/MI Market Value and Volume Forecast (2019-2024) 7.2.3 AF Market Value and Volume Forecast (2019-2024) 7.2.4 Others Market Value and Volume Forecast (2019-2024) 8 Vitamin K Antagonists (Vka) Market Analysis and Forecast by Countries 8.1 Germany Market Value and Consumption Forecast (2019-2024) 8.2 UK Market Value and Consumption Forecast (2019-2024) 8.3 France Market Value and Consumption Forecast (2019-2024) 8.4 Italy Market Value and Consumption Forecast (2019-2024) 8.5 Spain Market Value and Consumption Forecast (2019-2024) 8.6 Russia Market Value and Consumption Forecast (2019-2024) 9 New Project Feasibility Analysis 9.1 Industry Barriers and New Entrants SWOT Analysis 9.2 Analysis and Suggestions on New Project Investment 10 Research Finding and Conclusion 11 Appendix 11.1 Methodology 11.2 Research Data Source
List of Tables and Figures Figure Product Picture of Vitamin K Antagonists (Vka) Table Product Specification of Vitamin K Antagonists (Vka) Figure Market Concentration Ratio and Market Maturity Analysis of Vitamin K Antagonists (Vka) Figure Europe Vitamin K Antagonists (Vka) Value ($) and Growth Rate from 2014-2024 Table Different Types of Vitamin K Antagonists (Vka) Figure Europe Vitamin K Antagonists (Vka) Value ($) Segment by Type from 2014-2019E Figure Europe Vitamin K Antagonists (Vka) Market Share by Types in 2018 Figure Oral Picture Figure Injection Picture Table Different Applications of Vitamin K Antagonists (Vka) Figure Europe Vitamin K Antagonists (Vka) Value ($) Segment by Applications from 2014-2019E Figure Europe Vitamin K Antagonists (Vka) Market Share by Applications in 2018 Figure VTE Picture Figure ACS/MI Picture Figure AF Picture Figure Others Picture Table Research Countries of Vitamin K Antagonists (Vka) Figure Europe Vitamin K Antagonists (Vka) Market Share by Countries in 2018 Figure Germany Vitamin K Antagonists (Vka) Consumption Value ($) and Growth Rate (2014-2019E) Figure UK Vitamin K Antagonists (Vka) Consumption Value ($) and Growth Rate (2014-2019E) Figure France Vitamin K Antagonists (Vka) Consumption Value ($) and Growth Rate (2014-2019E) Figure Italy Vitamin K Antagonists (Vka) Consumption Value ($) and Growth Rate (2014-2019E) Figure Spain Vitamin K Antagonists (Vka) Consumption Value ($) and Growth Rate (2014-2019E) Figure Russia Vitamin K Antagonists (Vka) Consumption Value ($) and Growth Rate (2014-2019E) Table Emerging and Growing Market of Vitamin K Antagonists (Vka) Table Industry News Table Industry Policies Figure Industry Chain Analysis of Vitamin K Antagonists (Vka) Table Upstream Raw Material Suppliers of Vitamin K Antagonists (Vka) with Contact Information Table Major Players Manufacturing Base and Market Share of Vitamin K Antagonists (Vka) in 2018 Table Major Players Consumption Value Market Share of Vitamin K Antagonists (Vka) in 2018 Table Major Players Vitamin K Antagonists (Vka) Product Types in 2018 Figure Consumption Process of Vitamin K Antagonists (Vka) Figure Manufacturing Cost Structure of Vitamin K Antagonists (Vka) Figure Channel Status of Vitamin K Antagonists (Vka) Table Major Distributors of Vitamin K Antagonists (Vka) with Contact Information Table Major Downstream Buyers of Vitamin K Antagonists (Vka) with Contact Information Table Europe Vitamin K Antagonists (Vka) Value ($) by Type (2014-2019E) Table Europe Vitamin K Antagonists (Vka) Value Share by Type (2014-2019E) Figure Europe Vitamin K Antagonists (Vka) Value Share by Type (2014-2019E) Table Europe Vitamin K Antagonists (Vka) Consumption by Type (2014-2019E) Table Europe Vitamin K Antagonists (Vka) Consumption Share by Type (2014-2019E) Figure Europe Vitamin K Antagonists (Vka) Consumption Share by Type (2014-2019E) Figure Oral Picture Figure Injection Picture Figure Europe Vitamin K Antagonists (Vka) Value ($) and Growth Rate of Injection Table Europe Vitamin K Antagonists (Vka) Price by Type (2014-2019E) Figure Downstream Market Overview Table Europe Vitamin K Antagonists (Vka) Consumption by Application (2014-2019E) Table Europe Vitamin K Antagonists (Vka) Consumption Market Share by Application (2014-2019E) Figure Europe Vitamin K Antagonists (Vka) Consumption Market Share by Application (2014-2019E) Figure Europe Vitamin K Antagonists (Vka) Consumption and Growth Rate of VTE (2014-2019) Figure Europe Vitamin K Antagonists (Vka) Consumption and Growth Rate of ACS/MI (2014-2019) Figure Europe Vitamin K Antagonists (Vka) Consumption and Growth Rate of AF (2014-2019) Figure Europe Vitamin K Antagonists (Vka) Consumption and Growth Rate of Others (2014-2019) Table Europe Vitamin K Antagonists (Vka) Value ($) by Countries (2014-2019E) Table Europe Vitamin K Antagonists (Vka) Value Market Share by Countries (2014-2019E) Figure Europe Vitamin K Antagonists (Vka) Value Market Share by Countries (2014-2019E) Table Europe Vitamin K Antagonists (Vka) Consumption by Countries (2014-2019E) Table Europe Vitamin K Antagonists (Vka) Consumption Market Share by Countries (2014-2019E) Figure Europe Vitamin K Antagonists (Vka) Consumption Market Share by Countries (2014-2019E) Table Europe Vitamin K Antagonists (Vka) Consumption, Value, Price and Gross Margin (2014-2019E) Table Germany Vitamin K Antagonists (Vka) Consumption, Value, Price and Gross Margin (2014-2019E) Table UK Vitamin K Antagonists (Vka) Consumption, Value, Price and Gross Margin (2014-2019E) Table France Vitamin K Antagonists (Vka) Consumption, Value, Price and Gross Margin (2014-2019E) Table Italy Vitamin K Antagonists (Vka) Consumption, Value, Price and Gross Margin (2014-2019E) Table Spain Vitamin K Antagonists (Vka) Consumption, Value, Price and Gross Margin (2014-2019E) Table Russia Vitamin K Antagonists (Vka) Consumption, Value, Price and Gross Margin (2014-2019E) Figure Top 3 Market Share of Vitamin K Antagonists (Vka) Companies in 2018 Figure Top 6 Market Share of Vitamin K Antagonists (Vka) Companies in 2018 Table Major Players Value ($) Share (2014-2019E) Table Company Profiles Table Product Introduction Table Lilly Sales, Value, Price, Gross Margin 2014-2019E Figure Lilly Sales and Growth Rate Figure Lilly Value ($) Market Share 2014-2019 Figure Lilly Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table AstraZeneca Sales, Value, Price, Gross Margin 2014-2019E Figure AstraZeneca Sales and Growth Rate Figure AstraZeneca Value ($) Market Share 2014-2019 Figure AstraZeneca Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Bristol-Myers Squibb Sales, Value, Price, Gross Margin 2014-2019E Figure Bristol-Myers Squibb Sales and Growth Rate Figure Bristol-Myers Squibb Value ($) Market Share 2014-2019 Figure Bristol-Myers Squibb Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table The Medicines Company Sales, Value, Price, Gross Margin 2014-2019E Figure The Medicines Company Sales and Growth Rate Figure The Medicines Company Value ($) Market Share 2014-2019 Figure The Medicines Company Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Genentech (Roche) Sales, Value, Price, Gross Margin 2014-2019E Figure Genentech (Roche) Sales and Growth Rate Figure Genentech (Roche) Value ($) Market Share 2014-2019 Figure Genentech (Roche) Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Boehringer Ingelheim Sales, Value, Price, Gross Margin 2014-2019E Figure Boehringer Ingelheim Sales and Growth Rate Figure Boehringer Ingelheim Value ($) Market Share 2014-2019 Figure Boehringer Ingelheim Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Bayer Sales, Value, Price, Gross Margin 2014-2019E Figure Bayer Sales and Growth Rate Figure Bayer Value ($) Market Share 2014-2019 Figure Bayer Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Aspen Sales, Value, Price, Gross Margin 2014-2019E Figure Aspen Sales and Growth Rate Figure Aspen Value ($) Market Share 2014-2019 Figure Aspen Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Pfizer Sales, Value, Price, Gross Margin 2014-2019E Figure Pfizer Sales and Growth Rate Figure Pfizer Value ($) Market Share 2014-2019 Figure Pfizer Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Johnson & Johnson Sales, Value, Price, Gross Margin 2014-2019E Figure Johnson & Johnson Sales and Growth Rate Figure Johnson & Johnson Value ($) Market Share 2014-2019 Figure Johnson & Johnson Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Daiichi Sankyo Sales, Value, Price, Gross Margin 2014-2019E Figure Daiichi Sankyo Sales and Growth Rate Figure Daiichi Sankyo Value ($) Market Share 2014-2019 Figure Daiichi Sankyo Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Otsuka Sales, Value, Price, Gross Margin 2014-2019E Figure Otsuka Sales and Growth Rate Figure Otsuka Value ($) Market Share 2014-2019 Figure Otsuka Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Sanofi Sales, Value, Price, Gross Margin 2014-2019E Figure Sanofi Sales and Growth Rate Figure Sanofi Value ($) Market Share 2014-2019 Figure Sanofi Market Share of Vitamin K Antagonists (Vka) Segmented by Region in 2018 Table Europe Vitamin K Antagonists (Vka) Market Value ($) Forecast, by Type Table Europe Vitamin K Antagonists (Vka) Market Volume Forecast, by Type Table Europe Market Value ($) Forecast by Application (2019-2024) Table Europe Market Volume Forecast by Application (2019-2024) Figure Germany Market Value ($) and Growth Rate Forecast (2019-2024) Figure Germany Consumption and Growth Rate Forecast (2019-2024) Figure UK Market Value ($) and Growth Rate Forecast (2019-2024) Figure UK Consumption and Growth Rate Forecast (2019-2024) Figure France Market Value ($) and Growth Rate Forecast (2019-2024) Figure France Consumption and Growth Rate Forecast (2019-2024) Figure Italy Market Value ($) and Growth Rate Forecast (2019-2024) Figure Italy Consumption and Growth Rate Forecast (2019-2024) Figure Spain Market Value ($) and Growth Rate Forecast (2019-2024) Figure Spain Consumption and Growth Rate Forecast (2019-2024) Figure Russia Market Value ($) and Growth Rate Forecast (2019-2024) Figure Russia Consumption and Growth Rate Forecast (2019-2024) Figure Industry Resource/Technology/Labor Importance Analysis Table New Entrants SWOT Analysis Table New Project Analysis of Investment Recovery
  • PRICE
  • $3440
    $4500
    Buy Now

Our Clients